Patents by Inventor Helena Ceric

Helena Ceric has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230271967
    Abstract: The present disclosure encompasses solid state forms of Fezolinetant, including salts and cocrystals of Fezolinetant, in embodiments crystalline polymorphs of Fezolinetant, processes for preparation thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 4, 2021
    Publication date: August 31, 2023
    Inventors: Helena Ceric, Nikolina Janton
  • Publication number: 20230097240
    Abstract: The present disclosure encompasses solid state forms of Asciminib and salts thereof, in embodiments crystalline poly-morphs of Asciminib and salts thereof, processes for preparation thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: January 28, 2021
    Publication date: March 30, 2023
    Inventors: Nikolina Janton, Helena Ceric
  • Patent number: 11427533
    Abstract: Disclosed are crystalline polymorphs of Bardoxolone methyl, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: August 30, 2022
    Assignee: PLIVA HRVATSKA D.O.O.
    Inventors: Ivana Landeka, Helena Ceric
  • Publication number: 20220041598
    Abstract: The present disclosure relates to Ribociclib solid state forms, Ribociclib salts including Ribociclib succinate and solid state forms thereof, as well as processes for preparation thereof and pharmaceutical compositions thereof.
    Type: Application
    Filed: October 25, 2021
    Publication date: February 10, 2022
    Inventors: Helena Ceric, Elisa Vergani, Paolo S. Tiseni, Hana Kantor, Piero Paravidino, Nikolina Janton, Christian Galluzzo, Alexandr Jegorov
  • Publication number: 20220024924
    Abstract: The present disclosure relates to solid state forms of Lumateperone besylate and Lumateperone tosylate:R-(?)-mandelic acid, to various intermediates, to processes for their preparation and the preparation of Lumateperone or salt thereof, to pharmaceutical compositions and their use for the treatment of central nervous system disorders.
    Type: Application
    Filed: November 27, 2019
    Publication date: January 27, 2022
    Inventors: Nikolina Janton, Helena Ceric, Sanja Matecic Musanic, Natasa Mrsic, Lidija Lerman, Tina D. Momcilovic, Ivana Sagud, Alexandr Jegorov
  • Patent number: 11155545
    Abstract: The present disclosure relates to Ribociclib solid state forms, Ribociclib salts including Ribociclib succinate and solid state forms thereof, as well as processes for preparation thereof and pharmaceutical compositions thereof.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: October 26, 2021
    Assignee: Sicor—Societa Italiana Corticosteroid s.r.l.
    Inventors: Helena Ceric, Elisa Vergani, Paolo S. Tiseni, Hana Kantor, Piero Paravidino, Nikolina Janton, Christian Galluzzo, Alexandr Jegorov
  • Publication number: 20200223791
    Abstract: Disclosed are crystalline polymorphs of Bardoxolone methyl, and pharmaceutical compositions thereof.
    Type: Application
    Filed: July 12, 2018
    Publication date: July 16, 2020
    Inventors: Ivana LANDEKA, Helena CERIC
  • Publication number: 20200190084
    Abstract: The present disclosure relates to Ribociclib solid state forms, Ribociclib salts including Ribociclib succinate and solid state forms thereof, as well as processes for preparation thereof and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 22, 2018
    Publication date: June 18, 2020
    Inventors: Helena Ceric, Elisa Vergani, Paolo S. Tiseni, Hana Kantor, Piero Paravidino, Nikolina Janton, Christian Galluzzo, Alexandr Jegorov
  • Patent number: 10640487
    Abstract: The present disclosure relates to solid state forms of Nilotinib fumarate and Nilotinib hydrochloride L-tartaric acid co-crystals, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: May 5, 2020
    Assignee: Teva Pharmaceuticals USA, Inc.
    Inventors: Helena Ceric, Igor Avdejev, Edi Topic
  • Publication number: 20190071426
    Abstract: The present disclosure relates to solid state forms of Nilotinib fumarate and Nilotinib hydrochloride L-tartaric acid co-crystals, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: March 13, 2017
    Publication date: March 7, 2019
    Inventors: Helena CERIC, Igor AVDEJEV, Edi TOPIC
  • Publication number: 20170305936
    Abstract: Solid state forms of Crisaborole and salts thereof, processes for preparation thereof and pharmaceutical compositions thereof are disclosed.
    Type: Application
    Filed: July 12, 2017
    Publication date: October 26, 2017
    Inventors: Helena Ceric, Marica Malenica, Marina Ratkaj, Ivana Landeka, Alexandr Jegorov
  • Patent number: 8372822
    Abstract: New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: February 12, 2013
    Assignee: Pliva Hrvatska D.O.O.
    Inventors: Edislav Leksic, Helena Ceric, Tina Mundorfer, Irena Zrinski Antonac, Zrinka Mastelic Samardzic
  • Publication number: 20120238612
    Abstract: New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.
    Type: Application
    Filed: June 1, 2012
    Publication date: September 20, 2012
    Applicant: PLIVA HRVATSKA D.O.O.
    Inventors: Edislav LEKSIC, Helena CERIC, Tina MUNDORFER, Irena Zrinski ANTONAC, Zrinka Mastelic SAMARDZIC
  • Patent number: 8217021
    Abstract: New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: July 10, 2012
    Assignee: Pliva Hrvatska D.O.O.
    Inventors: Edislav Leksic, Helena Ceric, Tina Mundorfer, Irena Zrinski Antonac, Zrinka Mastelic Samardzic
  • Publication number: 20120022124
    Abstract: New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.
    Type: Application
    Filed: August 4, 2011
    Publication date: January 26, 2012
    Applicant: PLIVA HRVATSKA D.O.O.
    Inventors: Edislav LEKSIC, Helena CERIC, Tina MUNDORFER, Irena Zrinski ANTONAC, Zrinka Mastelic SAMARDZIC
  • Patent number: 8022093
    Abstract: New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.
    Type: Grant
    Filed: April 19, 2011
    Date of Patent: September 20, 2011
    Assignee: Pliva Hrvatska D.O.O.
    Inventors: Edislav Leksic, Helena Ceric, Tina Mundorfer, Irena Zrinski Antonac, Zrinka Mastelic Samardzic
  • Publication number: 20110196008
    Abstract: New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.
    Type: Application
    Filed: April 19, 2011
    Publication date: August 11, 2011
    Applicant: PLIVA HRVATSKA D.O.O.
    Inventors: Edislav LEKSIC, Helena CERIC, Tina MUNDORFER, Irena Zrinski ANTONAC, Zrinka Mastelic SAMARDZIC
  • Patent number: 7956048
    Abstract: New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.
    Type: Grant
    Filed: April 1, 2010
    Date of Patent: June 7, 2011
    Assignee: Pliva Hrvatska D.O.O.
    Inventors: Edislav Leksic, Helena Ceric, Tina Mundorfer, Irena Zrinski Antonac, Zrinka Mastelic Samardzic
  • Publication number: 20100256212
    Abstract: New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.
    Type: Application
    Filed: April 1, 2010
    Publication date: October 7, 2010
    Applicant: PLIVA HRVATSKA D.O.O.
    Inventors: Edislav LEKSIC, Helena CERIC, Tina MUNDORFER, Irena Zrinski ANTONAC, Zrinka Mastelic SAMARDZIC
  • Publication number: 20090137613
    Abstract: The present invention is concerned with new pharmaceutically acceptable salts of valacyclovir, polymorphic forms, processes for preparing the new pharmaceutically acceptable salts and new polymorphic forms, pharmaceutical compositions containing the same, therapeutic uses thereof and methods of treatment employing the same.
    Type: Application
    Filed: March 6, 2007
    Publication date: May 28, 2009
    Inventors: Helena Ceric, Zvonimir Siljkovic, Iva Tunjic, Aleksandar Danilovski, Ernest Mestrovic